Latest From This Author
Soros Fund Management, the closely watched investment fund, has sold its sizable stake in Los Angeles nutritional products company Herbalife Ltd., according to a regulatory filing.
The gig: Hakan Edstrom, 65, is chief executive of MannKind Corp., which developed an inhaled insulin drug that could replace injections for people with diabetes.
The opening salvo in a potential war for the Orange County Register was launched in Bankruptcy Court on Wednesday, with an attorney for the owner of the Los Angeles Times calling for an “open sale process” for the rival, struggling newspaper.
Before the group of East Coast investors arrived late last year, Camarillo pharmacist Russell Reitz had been promoting his modest prescription-filling business as “your local pharmacy.”
Kite Pharma, one of the hottest biotech start-ups on Wall Street, hopes to revolutionize the treatment of a common, deadly lymphatic cancer — with a novel mix of highly trained lab techs and high-speed air travel.
Kaiser Permanente was the highest-rated HMO and Anthem Blue Cross and Cigna the top-rated PPOs in a new state report.
The nation’s largest pharmacy benefits manager said it would cover two pricey new cholesterol drugs, including one by Amgen Inc., but limit them to patients who need them most.
Volkswagen’s stunning admission that it rigged its diesel cars to pass emissions tests is setting up one of the largest, costliest legal cases in U.S. history.
